556 Followers on Owler

Immusoft

is a Washington-based clinical-stage biotechnology company that researches and develops novel therapies for the treatment of genetic diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Immusoft

is a Washington-based clinical-stage biotechnology company that researches and develops novel therapies for the treatment of genetic diseases... Read more
Immusoft Chairman & CEO: Sean Ainsworth

Chairman & CEO

Sean Ainsworth

CEO Approval Rating

90/100

2009

PrivateIndependent Company

Pharmaceuticals & Biotechnology
Biotechnology
28342836 NAICS listing

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$49.7M
Acquisitions
1

News

Funding
May 27, 2024
SEC
Immusoft received $4.6M in Equity Funding

Immusoft Competitors

1NexImmune
2Corvus
3bluebird bio
4Checkmate Pharmaceuticals
5Aura
6Juno Therapeutics
7Perthera
8Kite Pharma
9Altor BioScience
10Dynavax
Unlock 11 + competitors

Trending Companies